INGN
Inogen Inc
NASDAQ: INGN · HEALTHCARE · MEDICAL DEVICES
$7.11
+1.57% today
Updated 2026-04-30
Market cap
$197.44M
P/E ratio
—
P/S ratio
0.57x
EPS (TTM)
$-0.86
Dividend yield
—
52W range
$5 – $9
Volume
0.3M
Inogen Inc (INGN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-6.52%
Operating margin
-12.20%
ROE
-12.40%
ROA
-6.35%
Debt/equity
0.09x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | $30.63M | $-2.00M | 48.00% | -5.62% | -6.54% |
| 2012 | $48.58M | $564000.00 | 49.30% | 1.71% | 1.16% |
| 2013 | $75.44M | $25.43M | 51.68% | 5.92% | 33.71% |
| 2014 | $112.54M | $6.83M | 49.33% | 9.34% | 6.07% |
| 2015 | $159.00M | $11.59M | 47.96% | 9.47% | 7.29% |
| 2016 | $202.83M | $20.52M | 47.98% | 11.27% | 10.12% |
| 2017 | $249.44M | $21.00M | 48.60% | 11.06% | 8.42% |
| 2018 | $358.11M | $51.84M | 49.87% | 10.58% | 14.48% |
| 2019 | $361.94M | $20.95M | 47.48% | 5.47% | 5.79% |
| 2020 | $308.49M | $-5.83M | 44.79% | -3.90% | -1.89% |
| 2021 | $358.00M | $-6.33M | 49.30% | 2.58% | -1.77% |
| 2022 | $377.24M | $-83.77M | 40.70% | -22.60% | -22.21% |
| 2023 | $315.66M | $-102.45M | 40.14% | -34.65% | -32.46% |
| 2024 | $335.70M | $-35.89M | 46.09% | -12.66% | -10.69% |
| 2025 | $348.67M | $-22.75M | 47.58% | -8.66% | -6.52% |